MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 4 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,085,000 | +2.6% | 1,214,647 | -18.0% | 0.00% | 0.0% |
| Q1 2020 | $3,006,000 | +179.6% | 1,480,387 | +197.6% | 0.00% | – |
| Q4 2019 | $1,075,000 | +4200.0% | 497,518 | +2924.2% | 0.00% | – |
| Q3 2019 | $25,000 | -53.7% | 16,451 | +19.4% | 0.00% | – |
| Q2 2019 | $54,000 | +12.5% | 13,783 | +20.2% | 0.00% | – |
| Q1 2019 | $48,000 | -55.6% | 11,464 | -69.6% | 0.00% | – |
| Q4 2018 | $108,000 | -90.6% | 37,659 | -67.3% | 0.00% | – |
| Q3 2018 | $1,151,000 | +53.3% | 115,091 | +8.4% | 0.00% | – |
| Q2 2018 | $751,000 | +101.3% | 106,203 | +8.7% | 0.00% | – |
| Q1 2018 | $373,000 | +631.4% | 97,716 | +928.7% | 0.00% | – |
| Q1 2016 | $51,000 | – | 9,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |